Data / Form D filings / Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc.: Form D filings
Biostar Pharmaceuticals, Inc., a pharmaceuticals company in Xianyang, Shaanxi, filed 2 Form D notices with the SEC in 2009. The latest, on November 25, 2009, reports $2.1 million sold of a $2.1 million offering to 13 investors.
Find out what Biostar Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- No. 588 Shiji Xi Road, Xianyang, Shaanxi, 71204
- Phone
- 86-29-33686638
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Maryland
- Year incorporated
- 2007
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1418133
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2009 | New notice | $2,120,000 | $2,120,000 | $0 | 13 | Nov 18, 2009 | sec.gov |
| Nov 13, 2009 | New notice | $3,605,000 | $3,605,000 | $0 | 14 | Nov 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronghua Wang | Executive Officer, Director | |
| Qinghua Liu | Director | |
| Elaine Zhao | Executive Officer | |
| Michael Segal | Director | |
| Amei Zhang | Executive Officer | |
| Haipeng Wu | Director | |
| Xifeng Nie | Director | |
| Shuang Gong | Executive Officer |
Every Form D from the week of Nov 23, 2009 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Biostar Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.